← All companies

ABVX

ABIVAX Société Anonyme

ABVX Nasdaq Pharmaceutical Preparations EDGAR ↗

$124.78

+0.45 +0.36%

Key statistics

from XBRL data in SEC filings

Market cap

$9.80B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$67.09 – $148.83

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 2, 2026 6-K Jun 29, 2026 6-K Jun 2, 2026 6-K May 22, 2026 6-K May 20, 2026 6-K May 7, 2026 6-K Apr 20, 2026 20-F Mar 23, 2026 6-K Mar 23, 2026 6-K Feb 23, 2026 6-K Dec 15, 2025 6-K Sep 8, 2025 6-K Jul 24, 2025 6-K Jul 22, 2025 6-K Jun 11, 2025 6-K Jun 2, 2025 6-K Apr 29, 2025 6-K Apr 22, 2025 20-F Mar 24, 2025 6-K Mar 24, 2025 6-K Jan 10, 2025 6-K Dec 23, 2024 6-K Nov 19, 2024 6-K Nov 14, 2024 6-K FORM 6-K Oct 3, 2024 6-K FORM 6-K Oct 3, 2024 6-K FORM 6-K Sep 26, 2024 6-K FORM 6-K Sep 25, 2024 6-K FORM 6-K Sep 9, 2024 6-K Sep 9, 2024 6-K FORM 6-K Aug 6, 2024 6-K FORM 6-K Jul 16, 2024 6-K Jun 4, 2024 6-K FORM 6-K May 7, 2024 20-F Apr 5, 2024 6-K FORM 6-K Apr 2, 2024 6-K FORM 6-K Feb 2, 2024 6-K FORM 6-K Jan 22, 2024

Other filings

SCHEDULE 13D/A Jul 6, 2026 424B5 Jul 2, 2026